China · Medical devices startup

Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd.

JJET (est. 2002) is a pioneer in cardiac electrophysiology in China, dedicated to R&D, production, and sales of high‐end diagnostic and ablation systems and consumables.

Funding reportedLast round: Series B

Medical devicesChengdu, China

About Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd.

JJET (est. 2002) is a pioneer in cardiac electrophysiology in China, dedicated to R&D, production, and sales of high‐end diagnostic and ablation systems and consumables.

Leveraging 20+ years of insight in bio-electric signals and electric engineering, we offer advanced and comprehensive solutions for tachyarrhythmia treatment. Our core technology platforms encompass cardiac navigation, modeling, pulsed field ablation (PFA), and RF ablation. We are the first in China to introduce a 3D integrated PFA system and multi-functional PFA catheters.

What company datasets say Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd. raised

Funding, as reported

Reported in all700Min the source's currency
Rounds3
Last roundSeries B
Last round size55M
Last round dateAug 2022
Investors listed8

The company, in detail

What they build

Known for

medical equipment manufacturinghospital & health caremedical equipmentsep cathetersmedical devicesinterventional cardiology3d cardiac mapping systemcardiac rf ablation generatorablation catheterelectrophysiology recording systemcardiac rf generator

Built with from their website

Google Tag ManagerWOWMicrosoft.netBaiduViewport Meta.NETASP.NETMobile FriendlyBootstrapjQuery

+8 more

SwiperC#ICPAlibaba Cloud MailGoogle AnalyticsPopperAnimate.cssMicrosoft Office

Sector
Medical devices
Region
Sichuan
Full record
Every detail in the company directory

Medical devices in China

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd. in front of investors. Or tell us what we have wrong.